
A Nature Metabolism study challenges universal blood NAD decline with age. What the findings mean for supplements, travel and physical capability.

On November 4, 2026, a study published in Nature Metabolism challenged the assumption that whole-blood NAD inevitably falls with age. Among participants classified as healthy, researchers found no significant age association in men and a modest increase with age in women. If your priorities include long walking days and independent travel, this finding is a reason to examine a familiar longevity claim more closely.
The practical question is not simply whether a blood measurement changes. It is whether an intervention helps you preserve the strength and energy to keep doing what matters. This research sharpens that distinction.
According to the Nature Metabolism paper, the cross-sectional population analysis included 1,068 adults: 636 women and 432 men. The broader research programme reported 1,340 whole-blood NAD measurements. Those figures describe different things: the number of participants in the main analysis and the measurements collected across the wider programme.
The researchers used dried blood spots collected under standardized morning fasting conditions. They measured total whole-blood NAD, meaning the sum of NAD⁺ and NADH. That is the specific measurement at the center of this finding.
Among healthy men, the authors found no statistically significant association between age and whole-blood NAD. Among healthy women, they found a modest positive association. The reported female slope was 0.07 µM per year, which the authors describe as subtle enough that detecting it likely required a large female cohort.
The important result is the pattern rather than the decimal: these data did not show a universal downward relationship between age and blood NAD. That challenges a simple account in which getting older automatically means having less NAD in the blood.
The study also found lower whole-blood NAD in participants with cardiovascular disease and hypertension. The authors conclude that this measurement tracked cardiovascular health more clearly than chronological age in their data. Their interpretation is that whole-blood NAD reflects a regulated metabolic state shaped by factors including sex and cardiovascular health.
This changes the question worth asking about a result. Rather than assuming that age explains it, the research points toward the importance of health context. A laboratory value becomes more informative when its meaning is understood, not merely when it is placed on a scale from low to high.
The authors identify important boundaries that keep this finding from becoming another overly broad longevity claim:
These boundaries preserve the useful conclusion: the assumption of universal age-related blood NAD decline deserves reconsideration.
According to the study authors, interest in nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) has been driven partly by the proposed role of age-related tissue NAD depletion. These substances are NAD precursors. The new findings complicate the idea that healthy adults share an age-related shortage that broadly needs correcting.
The paper included a small observation involving two people who self-administered NMN. Their measured whole-blood NAD rose during use. This was not a controlled efficacy trial and did not establish clinical benefit or an appropriate dose; the authors also say the long-term consequences of sustained high NAD levels in humans are unknown.
The wider human evidence remains unsettled. The Conversation reports that a review of 33 human studies found inconsistent effects of NAD-precursor supplements on physical function, metabolism and other healthy-aging measures. Its account calls for larger and longer trials to determine whether supplementation meaningfully affects healthspan or lifespan.
The Nature Metabolism authors conclude that their results do not provide a broad rationale for NAD-boosting interventions in healthy adults. They leave open the possibility that condition-specific uses warrant further study. That is a narrower position than either endorsing these products for everyone or dismissing every possible application.
For readers following our coverage of nutrition and metabolism, the distinction is useful: changing a measurement and improving a person's life are separate scientific questions.
For an active traveler, the value of a longevity intervention lies in what it helps you do. Recovering after a demanding journey and enjoying a full day outdoors are meaningful goals. Applying this study as evidence for better travel recovery, altitude adjustment or sustained sporting energy would go beyond its results.
The practical response is to bring one outcome-focused question to a qualified healthcare professional before making a personal NAD-supplement decision: What human evidence shows that this improves the capability I care about?
Keep the intended benefit specific during that conversation. Recovery after a long journey and adjustment to altitude are different outcomes. Naming the one that matters prevents a general claim about “healthy aging” from standing in for evidence relevant to your plans.
For example, a claim that a product raises blood NAD addresses a measurement. A claim that it helps you feel ready for a mountain itinerary addresses your experience and function. The first should not be accepted as proof of the second.
That perspective fits naturally into health planning before your next journey. The point is not to add a complicated preparation routine. It is to make the supplement discussion relevant to the trip you actually intend to take.
For skiing or hiking, make sustained energy the focus of the same question. A persuasive answer should concern a meaningful physical outcome rather than rely entirely on the appeal of a cellular mechanism. The reported inconsistency in human supplementation research makes that distinction especially important.
This is an outcome-first way of thinking about fitness that connects with real-world capability. A laboratory target is not the reason you want to stay active. The reason is the freedom to choose a demanding route and participate in the activities you enjoy.
At WealthAtPlay, the focus is staying strong, sharp, mobile and capable for longer. This study supports a more careful conversation about the evidence behind that goal. You can take the science seriously without treating every age-related theory as a reason to add another product to your routine.
Keep your routine anchored to the capabilities you want to preserve, and discuss NAD supplements in terms of demonstrated human outcomes rather than assuming that age alone means your blood NAD needs correcting.
Stay connected for research and practical guidance on longevity, strength, recovery, energy and active living. New ideas to help you stay capable, curious and ready for more.



Explore practical guidance on strength, recovery, energy, travel and longevity for a life that stays active.
explore the Blog